Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells known as CD8+ T cells can make the cells more robust, potentially opening the door for better use of people's own immune system T cells to fight cancer. The findings were published Oct. 3 in the journal JCI-Insight . "Maximizing the effectiveness of T-cell-based therapies remains a critical challenge," says David Kass, M.

https://www.miragenews.com/super-t-cells-created-through-protein-mutation-1096485/

#miragenews